Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Orchestra BioMed Holdings, Inc. (OBIO : NSDQ)

• Company Description    Orchestra BioMed Inc. is a biomedical company accelerating high-impact technologies to patients. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy(TM)for the treatment of hypertension and Virtue(R) Sirolimus AngioInfusion(TM) Balloon for the treatment of atherosclerotic artery disease. Orchestra BioMed Inc., formerly known as Health Sciences Acquisitions Corporation 2, is based in NEW HOPE, Pa. Number of Employees: 70

• Price / Volume Information    Yesterday's Closing Price: $3.00 Daily Weekly Monthly 20 Day Moving Average: 358,500 shares Shares Outstanding: 38.31 (millions) Market Capitalization: $114.94 (millions) Beta: 0.61 52 Week High: $8.87 52 Week Low: $2.37 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.06% -8.62% 12 Week 5.26% -11.46% Year To Date -25.00% -29.76%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 150 UNION SQUARE DRIVE - NEW HOPE,PA 18938 USA ph: 215-862-5797 fax: - snewcomb@orchestrabiomed.com https://orchestrabiomed.com

• General Corporate Information    Officers David P. Hochman - Chief Executive Officer; Chairperson and Director Darren R. Sherman - President; Chief Operating Officer and Director Andrew L. Taylor - Chief Financial Officer Joshua Aiello - Corporate Controller Jason Aryeh - Director Peer Information Orchestra BioMed Holdings, Inc. (CORR.) Orchestra BioMed Holdings, Inc. (RSPI) Orchestra BioMed Holdings, Inc. (CGXP) Orchestra BioMed Holdings, Inc. (BGEN) Orchestra BioMed Holdings, Inc. (GTBP) Orchestra BioMed Holdings, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 68572M106 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/11/25 Share - Related Items Shares Outstanding: 38.31 Most Recent Split Date: (:1) Beta: 0.61 Market Capitalization: $114.94 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.51 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.00 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 6.82 Price/Cash Flow: - Price / Sales: 39.83 EPS Growth vs. Year Ago Period: -28.95% vs. Previous Quarter: -13.95% Sales Growth vs. Year Ago Period: 40.00% vs. Previous Quarter: 243.08% ROE 06/30/25 - - 03/31/25 - -189.26 12/31/24 - -135.24 ROA 06/30/25 - - 03/31/25 - -93.76 12/31/24 - -79.64 Current Ratio 06/30/25 - - 03/31/25 - 3.35 12/31/24 - 4.27 Quick Ratio 06/30/25 - - 03/31/25 - 3.34 12/31/24 - 4.26 Operating Margin 06/30/25 - - 03/31/25 - -2,297.85 12/31/24 - -2,313.27 Net Margin 06/30/25 - - 03/31/25 - -2,297.85 12/31/24 - -2,313.27 Pre-Tax Margin 06/30/25 - - 03/31/25 - -2,297.85 12/31/24 - -2,313.27 Book Value 06/30/25 - - 03/31/25 - 0.44 12/31/24 - 0.87 Inventory Turnover 06/30/25 - - 03/31/25 - 1.40 12/31/24 - 1.38 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.85 12/31/24 - 0.43 Debt-to-Capital 06/30/25 - - 03/31/25 - 45.96 12/31/24 - 30.25

Powered by Zacks Investment Research ©